Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY
No-Receipt date
2012-03004 - 27/09/2012
No-Filing date
20120402169 - 27/09/2012
No-Granting date
3079004 - 28/09/2012
No-EPO application date
05756320.7 - 20/05/2005
No-EPO granting date
1758610 - 04/07/2012
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
9/2012 - 15/09/2012
Expiration date
21/05/2025
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US572973 P20/05/2004/US
US635380 P10/12/2004/US
US671281 P14/04/2005/US
US680447 P12/05/2005/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 35/00
A61K 39/395
A61K 38/20
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
431998
ZYMOGENETICS, INC.
1201 EASTLAKE AVENUE EAST
SEATTLE, WA 98102
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1025833
KINDSVOGEL, WAYNE, R.
1025834
HUGHES, STEVEN, D.
1025835
HOLLY, RICHARD, D.
1025836
CLEGG, CHRISTOPHER, H.
1025837
FOSTER, DONALD, C.
1025838
JOHNSON, REBECCA, A.
1025839
HEIPEL, MARK, D.
1025840
SIVAKUMAR, PALLAVUR, V.
Representatives
Code
Firstname
Surname
Address
Town
Zip
2849
MARIA
PAPANIKOLAOU
M. ASIAS 10, ANO PEYKI
PEFKI (ATTIKIS)
15121
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2897
ALKISTIS-EIRINI
MALAMI
SKOUFA 52
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
12/7/2016 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 11/2016 Αρ. Πρωτ. Γ.Δ. 1570/07.12.2016
Payments history
11 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).